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University of Connecticut, 2016
Therapeutic management of childhood diarrhea had led to a significant decrease in diarrhea
related morbidity and mortality. However, diarrhea diseases remain one of the leading cause of
preventable deaths worldwide, especially in children under 5 years. The work presented in this
dissertation intended to evaluate the current the management of childhood diarrhea, to identify
the major gaps in the management and introduce a novel approach to address these gaps. First, an
assessment of oral rehydration therapies (ORT) coverage in the management of childhood
diarrhea is performed to evaluate healthcare providers’ prescriptive practices of ORT in South
Asia. Next, we assess the effect of breastfeeding cessation in reported episodes of diarrhea using
a national database. The study highlighted suboptimal breastfeeding practices among American
mothers who participated in the study and its impact on reported onset of diarrhea episodes in
infants during their first year of life. The results show that breastfeeding cessation before the first
6 months is a significant predictor of diarrhea between 7 and 12 months. Lastly, sensitivity of a
diarrheagenic pathogen identification tool was tested in two laboratory simulated environments.
Despite the limitation of the experiments, the study offers insight of the tool’s properties under
specific environment, guiding future optimization. The manuscripts comprised in this
dissertation provide evidence for the need to re-evaluate the use of therapies known to be
effective and to conduct future research in innovative approach to the management of childhood
diarrhea.
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Allow yourself to dream,
And when you do dream big
Allow yourself to learn
And when you do learn all you can
Allow yourself to laugh
And when you do share your laughter
Allow yourself to set goals
And when you do reward yourself as you move forward
Allow yourself to be determined
And when you do you will find you will succeed
Allow yourself to believe in yourself
And when you do you will find self confidence
Allow yourself to lend a helping hand
And when you do a hand will help you.
Allow yourself relaxation
And when you do you will find new ideas.
Allow yourself love
And when you do you will find love in return
Allow yourself to be happy
And when you do you will influence others around you.
Allow yourself to be positive
And when you do life will get easier.
Catherine Pulsifer
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CHAPTER ONE

1

1.1 Childhood diarrhea: etiology and burden
Accounting for 9% of all death worldwide, approximately 578,000 children under the age
of 5 die from infectious diarrhea each year (Liu et al., 2015). Childhood diarrhea is chiefly
manifested as a symptom of intestinal tract infections. There are three major factors that must be
considered when defining diarrhea: the frequency of stool output, stool consistency and stool
weight (Pawlowski, Warren, & Guerrant, 2009). According to the World Health Organization
(WHO), diarrheal diseases is defined as followed:
“The passage of three or more loose or liquid stools per day, or more frequently than is
normal for the individual.”(World Health Organization, 2013)
Over the past 30 years, the therapeutic management of childhood diarrhea has led to a significant
decrease in under-five mortality. It has been estimated that mortality rates related to diarrheal
infections decreased by more than two fold, from 1.2 million in 2000 to half a million in 2015
(United Nations Children’s Funds, 2016).4 Even though this is a significant decrease, many of
these deaths are preventable with appropriate management strategies.
While child mortality has significantly decreased, diarrheal infections remain one of the
leading cause of death in children under the age of 5. Approximately 1.7 million episodes of
childhood diarrhea are reported each year, with 1,600 deaths occurring daily (Liu et al., 2015).
The majority of the burden caused by diarrheal diseases occur in low and middle income
countries where pathogen transmission occurs mainly through overcrowding, poor sanitation,
limited access to clean water and inadequate food hygiene (Leung, Chisti, & Pavia, 2016). South
Asia and Sub Saharan Africa alone account for 90% of the total childhood mortality rate due to
diarrhea (Liu et al., 2015).
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Diarrhea is caused by a number of pathogens including bacteria, viruses, protozoa and
helminths (Larson, Henning, Luby, & Faruque, 2009). A multiple sites birth cohort study (MALED) was conducted in eight different countries in South America, Sub-Saharan Africa and South
Asia between 2009 and 2014 to estimate the pathogen-specific burdens of diarrhea in children
between 0 to 2 years of age (Platts-Mills et al., 2015). The researchers reported that cases of
acute to persistent diarrhea in children under 2, were mainly attributed to norovirus, rotavirus,
Campylobacter spp, astrovirus and Shigella spp (Platts-Mills et al., 2015). Factors such as age,
location and climatic variability were also reported to have a significant impact on the incidence
of diarrhea. The authors (2015) concluded that significant reduction in the incidence of
childhood diarrhea, at the community level, could only be achieved by diversifying the diarrhea
control programs rather than focusing on a single-pathogen strategies.
1.2 Classification of diarrhea
Due to financial and technical constraints, diarrheal infections are often managed on the
basis of clinical symptoms rather than the identification of etiologic pathogens (Larson et al.,
2009) Diarrheal diseases can be classified in three major categories based on the clinical
presentations. They are: 1) acute watery diarrhea, 2) persistent diarrhea and 3) bloody diarrhea.
Each category is physiologically different, hence requiring specific diagnosis and management.
Acute watery diarrhea, also described as secretory diarrhea, is characterized by symptoms lasting
for less than 2 weeks (Pawlowski et al., 2009). It is mainly associated with small bowel
infections resulting in a decrease sodium absorption and an increase mucosal permeability as
well as chloride secretion (Pawlowski et al., 2009). The inflammatory process causes severe,
acute dehydration and electrolyte imbalance.
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Persistent diarrhea is diagnosed when an episode lasts for 2 to 4 weeks (Pawlowski et al.,
2009). Commonly caused by the inflammation of the small bowel, this type of diarrhea is
associated with nutritional malabsorption and chronic malnutrition. Children with persistent
diarrhea accompanied with chronic malnutrition can suffer from stunting, vitamin A deficiency,
other systemic infections and more severe diarrhea; setting them up in a viscious cycle (Keusch
et al., 2006). That is the reason why persistent diarrhea significantly increases the case- fatality
rates and have long-lasting impact on the quality of life (Keusch, Walker, Das, Horton, & Habte,
2016)
Bloody diarrhea, interchangeably called dysentery in the clinical setting, is commonly
associated with dehydration and fever (Keusch et al., 2006) This type of diarrhea is characterized
by traces of blood in the stool and is indicative of intestinal damage secondary to an
inflammation of the colon or distal part of the small intestine (Keusch et al., 2006; Keusch et al.,
2016; Pawlowski et al., 2009).
Based on these classifications, clinical management of childhood diarrhea has focused
primarily on the prevention and reduction of dehydration with oral rehydration therapy (ORT),
zinc supplementation and the maintenance of oral feeding, especially breastfeeding when
possible (World Health Organization, 2005). These preventive measures have been proven to
decrease stool output, frequency and duration of diarrhea episode. ORT and breastfeeding,
mainly, are described as the major contributors to the significant drop in childhood diarrhea
worldwide. The subsequent sections present, in more details, the properties and roles of ORT and
breastfeeding in the management of childhood diarrhea.
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1.3 Preventive and therapeutic management of childhood diarrhea
1.3.1 Oral rehydration therapy
The updated WHO guidelines on the clinical management of childhood diarrhea suggest
the use of low osmolality ORT containing decreased glucose and sodium concentrations (World
Health Organization, 2005). Studies demonstrated that the reduced osmolarity of oral rehydration
was safer than the original formulation of ORT and has been reported to decrease stool output by
20% (Hahn, Kim, & Garner, 2002). Recommendations for healthcare providers include
prescribing the solution volume based on the child’s weight and presenting signs of dehydration.
Oral rehydration works through several different mechanisms of the GI track. Intestinal
absorption of fluids and electrolytes results from ion transport processes across the transepithelial cell membrane (absorptive and secretory) and osmosis. Osmotic gradient is dictated by
sodium (Na+) transport (Figure 1) (Suh, Hahn, & Cho, 2010). Absorption of the organic solutes
(sugar, oligopeptide and amino acid) is accompanied with the absorption of Na+, which results in
water absorption via osmosis (Field, 2003).
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Figure 1. ORT mechanism. During an episode of diarrhea, there is massive loss of water and electrolytes mainly,
sodium ions (Na+). Coupled transport of sodium and glucose is preserved. Glucose facilitates Na+ reabsorption
(water follows) back into the cell on a 1:1 molar basis against concentration gradient through the glucose symporter,
sodium-glucose transporter type 1 (SGLT1). Na+ present in the epithelial cells is then pumped into the blood via
adenosine triphosphate (Na+K+ATPase). Transport of glucose into the blood is mediated by the glucose transporter 2
(GLUT2). (Duggan, Fontaine, Pierce, & et al., 2004).

During an episode of diarrheal infection, there is disruption of these mechanisms, with
the exception of the sodium absorption coupled with sugars and amino acids process (Suh et al.,
2010). The integrity of the latter mechanism in diarrheal diseases was discovered in the 1960’s
and has been the theoretical foundation of oral rehydration therapy (ORT) (Hoque, Chakraborty,
Sheikh, & Woodward, 2012) Considered the most important medical advance of the 20th century,
ORT has been the cornerstone in the prevention and management of childhood diarrhea
(Santosham et al., 2010).
Despite the success of the early diarrhea-control programs and the updated World Health
Organization guidelines, many children under the age of 5 still do not receive adequate treatment
during an episode of diarrhea. Recent reports indicated that only 40% of children suffering from
diarrhea worldwide, received oral rehydration or increased fluid intake with continued feeding as
part of their management (United Nation Children’s Funds, 2016). It is important to note, that
this degree of treatment is only 10% greater (approximately) than the 1995 global percentage of
children under 5 years who received oral rehydration as treatment for their diarrhea episode
(Fontaine et al., 2009). Even though ORT has been proven to be effective it is still not used
routinely by all health professionals worldwide in the management of childhood diarrhea.
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1.3.2 Breastfeeding
Since 1984, breastfeeding has been identified as one of the most important and costeffective intervention, significantly preventing and reducing the incidence of infectious diseases
in children, especially diarrhea and pneumonia (Field, 2003; Hoque et al., 2012; Suh et al.,
2010). Human breastmilk contains bioactive molecules, mostly secretory antibodies, lactoferrin
and glycans promoting protection and maturation of the gastrointestinal track and immune
system during infancy and early childhood (Brandtzaeg, 2010; Lamberti, Fischer Walker,
Noiman, Victora, & Black, 2011; Newburg, 2000; Zivkovic, German, Lebrilla, & Mills, 2011).
Exclusive breastfeeding during the first 6 months of life has been reported to offer the
best immune protection against diarrheal diseases. In a systematic review of the literature,
Lamberti and colleagues (2011) assessed the protective effect of optimal versus suboptimal
breastfeeding practices on diarrhea associated childhood morbidity, mortality and hospitalization
in low income countries. The study findings indicated that among infants between 0 and 5
months, those who were partially breastfed had 1.68 times (95% Confidence interval [1.03-2.76])
greater risk of having diarrhea compared to those who were exclusively breastfed (Lamberti et
al., 2011). The risk of hospitalization from diarrhea was 6.05 times greater in infants between 6
and 11months who were not breastfed compared to those who were breastfed (Lamberti et al.,
2011).
While the protective effect of breast milk is undeniable, significant gaps still exist in the
promotion and practice of early breastfeeding initiation and continuation for the first 6 months of
life, even in countries like the US. Non-exclusive or early interruption of breastfeeding, also
known as suboptimal breastfeeding, was ranked in 2010 by the Global Burden of Disease Study
as the second leading risk factor of disease burden in children under the age of 5 worldwide
7

regardless of whether the child was in a developed or under-developed country (Gaffney,
Kitsantas, & Cheema, 2012).
1.4 Overall goal of the dissertation
Even with these known findings and recommendations about how to prevent and manage
childhood diarrhea, a gap in the use of evidence-based practice strategies remains. The limited
use of oral rehydration solutions and exclusive breastfeeding practices for more than three
decades has been linked to the diversion of international funding towards malaria and AIDS after
the incorporation of diarrhea-control programs into the integrated management of childhood
illness (IMCI) approach (Fontaine et al., 2009). This incorporation of the diarrhea-control
programs into the integrated management of childhood illness (IMCI) has led to inconsistencies
in healthcare professionals training specific to diarrhea management (Fontaine et al., 2009).
Also lacking in the management of diarrhea in limited recourses settings is the diagnosis
based on laboratory testing. Current clinical management of diarrheal episodes are mostly
symptoms based (Kotloff et al., 2013). The diagnosis and treatment based only on clinical
symptoms can be inaccurate and result in the unnecessary use of broad spectrum antibiotics
(Pathak, Pathak, Marrone, Diwan, & Lundborg, 2011; Reddington, Tuite, Minogue, & Barry,
2014). There is, therefore, a critical need to develop a point-of-care pathogen identification tool
enabling fast and accurate identification of diarrheal pathogens.
The overall goal of this dissertation is to address these gaps and introduce a novel
approach in the management of diarrhea by healthcare professionals. The two studies reported in
chapter two and three examine the limited use of interventions such as ORT and breastfeeding in
the management of childhood diarrhea. The focus was only on these interventions because of
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their scientifically proven efficacy, their low to no cost value and their known success for more
than 30 years.
The two studies shed some lights on the limitations of the current diarrhea-control
programs. A systematic review of the literature has been performed in chapter two, to assess the
reported management of childhood diarrhea by trained physicians and pharmacists in South Asia;
where coverage of ORT increased by only 5% from 2000 to 2015 (United Nation Children’s
Funds., 2016).
The study presented in chapter three explores the protective effect of breastfeeding on
diarrhea outcomes during the first year of life, using a large cohort of infants in the United
States. The findings of the secondary data analysis suggest statistically strong evidence for the
protective effect of breastfeeding on the incidence of diarrheal episodes. The results also show
that suboptimal breastfeeding remains a public health issue even in developed countries like the
US.
Finally. The third study reports on the laboratory testing of a paper-based diarrheagenic
pathogens identification tool. The aim of this pilot study is to evaluate the effectiveness of a new
pathogen identification tool by determining it’s efficacy in identifying a common diarrheagenic
pathogen, E coli, under high temperature range; simulating the climate in the geographical areas
with the highest morbidity and mortality rates due to diarrhea. Such a tool has the potential to
help formulate accurate diagnosis and effective treatment of children suffering from diarrhea in a
timely manner, thus reducing the impact of diarrhea on childhood morbidity and mortality.
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1.5 Specific aims and hypotheses
Specific aim for study #1: To describe the use of ORT in the management of childhood
diarrhea by physicians and pharmacists as reported in observational studies performed in South
Asia. Hypothesis: In cases of childhood diarrhea, physicians and pharmacists will prescribe ORT
in limited proportions. Healthcare professionals (mainly physicians, pharmacists, midwives and
nurses) at the public and private levels play an important role in the management of childhood
diarrhea. Recent studies performed in South India and Sub-Saharan Africa have shown that,
regardless of receiving formal diarrhea management training, healthcare professionals treating
children with diarrhea tended to prescribe more antibiotics, injections and anti-diarrheal
medications than oral rehydration solutions and zinc (Pathak et al., 2011; Sood & Wagner,
2014).
Specific aim for study #2: To evaluate the impact of breastfeeding duration during the
first 6 months after birth, on the maternal reports of diarrhea episodes in infants during their first
year. Hypothesis: Compared to infants who discontinued breastfeeding between 0 and 6 months,
the infants who were breastfed up to 6 months or longer will have a lower count of diarrheal
episodes, reported by mothers within 2 weeks prior to completion of questionnaires at 7, 9, 10,
and 12 months. Multiple studies have shown that breastfeeding, the recommended source of
nutrition for at least the first six months of life, is essential for the nutritional, immunologic,
neurobehavioral and social development of the infant and young child (Group, 2016; Gupta,
Dadhich, & Suri, 2013).
Specific aim for study #3: To evaluate the efficacy of a pathogen identification tool in
detecting the presence of E. coli under simulated high temperature conditions similar to limited
resources settings with the highest morbidity and mortality rates due to diarrhea. Hypothesis: The
10

pathogen identification tool will accurately detect diarrheagenic pathogens under environmental
conditions that are specific to the region of the worlds most affected by diarrheal diseases. This
hypothesis is based on results of preliminary laboratory evaluation of the pathogen identification
tool.
To address the growing interest to develop diagnostic technologies targeting low-resource
settings, the WHO has outlined in seven points the characteristics point-of-care tests should have
(Kettler, White, & Hawkes, 2004; Mabey, Peeling, Ustianowski, & Perkins, 2004).
Corresponding to the acronym “ASSURED”, these tests should be: 1) affordable, 2) sensitive, 3)
specific, 4) user-friendly, 5) rapid and robust, 6) equipment-free, and 7) deliverable to end users
(Kettler et al., 2004). The successful completion of this study is in line with these criteria and is
expected to further optimize a point-of-care diarrhea pathogen identification tool appropriate to
resource-limited sites.
1.6 Conclusion
Inappropriate management of diarrhea episodes contribute to the slow progress made in
the last four decades to reduce mortality and morbidity due to diarrheal diseases. The findings of
each study presented in this dissertation will contribute to the understanding of the most current
management of childhood diarrhea and identify the gaps justifying the need to develop
alternative approach to continue reducing the impact of diarrhea in children. The development of
point-of-care diagnostics at the service of global health issues is critical to address the gap in
using adequate management measures, hence improving child survival and reducing morbidity
and mortality rates caused by diarrheal diseases.
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Abstract
Background: Oral rehydration therapies (ORT) has been the cornerstone of diarrheal control
programs and is associated with a significant drop in diarrhea related childhood mortality.
Despite the proven evidence and low cost, routine use of ORT remains limited.
Objectives: A systematic review of the literature was performed to evaluate healthcare providers
(medical doctors and pharmacists) ORT prescriptive practices during management of childhood
diarrhea.
Method: A meta-analysis of observational studies reporting on medical doctors and pharmacists
prescribing behaviors during management of childhood (ages 0 to 15 years) diarrhea in South
Asia was the initial intent of this work. Statistically significant evidence of study heterogeneity
was achieved, not allow for combining data across studies. Therefore, an integrative review was
completed following PRISMA guidelines. An electronic search was performed using PubMed,
Embase, Ovid Global Health and the World Health Organization (WHO) Global Health Library.
Studies reporting on healthcare providers’ ORT prescriptive practices during management of
diarrhea South Asia were included.
Results: Eighteen studies were included in the review. The lack of robust evidence and inability
to combine the findings in a meta-analysis were due to variations between studies’ design,
method, population and geographical settings. Overall study findings demonstrated considerable
variability in ORT coverage that was consistent regardless of publication before or after the 2004
WHO guidelines for the management of childhood diarrhea. Pharmacists and/or pharmacy
personnel were reported to prescribe lower rates of ORT compared to medical doctors and/or
health facilities workers.
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Conclusions: Available evidence demonstrates limited use of ORT during management of
childhood diarrhea by health providers in South Asia and that it is inconsistent with the 2004
WHO guideline. Variability in the study methodologies, designs, settings and reporting was
significant. Findings highlight the need for stronger study methodologies specifically related to
sampling, measurement and reporting of ORT in management of childhood diarrhea.
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2.1 Introduction
Worldwide, childhood mortality due to diarrheal diseases has dramatically decreased
from 4.6 million in 1980 to 526, 000 in 2015.1 This significant drop is primarily due to the
improved therapeutic management of diarrheal diseases which mainly includes: oral rehydration
therapy (ORT), zinc supplementation, and antibiotics for dysentery. Additional supportive
interventions include routine use of the rotavirus vaccine, vitamin A supplementation, initiation
and maintenance of breastfeeding, access to clean water, and hand washing with soap and water.2
Use of ORT alone as the first line treatment has the potential to reduce diarrhea mortality rates
by approximately 93 percent.3
Since the 1970’s, the World Health Organization (WHO) has continuously recommended
ORT for the prevention and treatment of dehydration caused by diarrhea.4 Over time, the
formulation of ORT has been extensively studied and refined to optimize reduction of stool
output while at the same time minimizing vomiting and other side effects such as
hypernatremia.4 Three decades of research have provided strong evidence to support the 2004
WHO recommendation for the use of a low osmolality ORT from 311mOsm/l (90mEq/L of
sodium) to 245mOsm/l (75mEq/l of sodium).5 The new formulation has been proven to reduce
stool output, vomiting, and the need for intravenous rehydration.3 Even with the existing
recommendations, many children suffering from diarrheal diseases do not receive ORT, the
appropriate recommended treatment.6
Regardless of the proven efficacy, low cost, and ease of use, the rate of ORT prescription
in the management of diarrheal episodes in the clinic setting or in the home remains stagnant. It
is estimated that worldwide only about 40% of children under the age of 5 suffering from
diarrhea receive ORT for the treatment of childhood diarrhea.6 For example, between 2000 and
19

2015 the use of ORT increased by only 4% (from 48% to 52%) in South Asia. As a
consequence, about 4.7 million episodes of childhood diarrhea are reported each year and
approximately 1,600 deaths associated with diarrhea occurring daily in South Asia.1
We performed a meta-analysis and integrative review to evaluate medical doctors and
pharmacists’ prescription of ORT in the management of childhood diarrhea in South Asia. We
chose South Asia as it is one of the regions of the world with the highest rate of childhood
mortality due to diarrhea.6 The study focuses only on observational study designs published
between 1988 and July 2016 to allow exploration of medical doctors and pharmacists’ ORT
prescription practices, in their natural setting, without an alteration of behaviors and patterns.8-10
We used Lipsey and Wilson method of meta-analysis (2001) to answer the following research
question:
What are the medical doctors and pharmacists’ ORT prescription behaviors as reported in
published observational design studies?
2.2 Method
2.2.1 Study retrieval
After problem statement formulation and eligibility criteria were confirmed, a literature
search was performed according to the Lipsey and Wilson method.10 Initial eligibility criteria
included research with an observational study design, published in English language and
research respondents being children under the age of 15 suffering from diarrhea or any
healthcare professionals providing treatment for childhood diarrhea.
The literature search was completed using five different databases including Pubmed,
Scopus, WHO Global Health Library as well as PsychInfo and Sociological abstract. The search
20

also included screening of references in related review articles and eligible studies. The
keywords and mesh terms used in combination were oral rehydration therapy, fluid therapy, oral
rehydration salts, oral rehydration solutions, sugar and salt solutions, diarrhoea, diarrhea,
chronic diarrhea, acute diarrhea, children, childhood, infant, toddler and pediatric. To ensure
that each study was comparable to the others and provided a consistent effect size statistic,
critical to producing strong analytical results, the literature search was further narrowed to the
health professional groups that were the most frequently reported in the studies to choose ORT
for diarrheal treatment; medical doctors and pharmacists.
2.2.2 Selecting, computing and coding the effect size statistics
Eligible studies were independently reviewed by two authors who then met to further
discuss inclusion of each study. The final selection was completed after the third reviewer
adjudicated on any uncertainty and disagreement about inclusion and exclusion. The encoding
process was then used for data extraction and to further organize each study’s findings. The
extracted data included information about: geographical location for study recruitment; the study
population; design; study objective; interventions; outcomes; and reported effect size statistics.10
Proportions of prescribed ORT during the management of childhood diarrhea by medical doctors
and/ or pharmacists were extracted and organized in a Microsoft (MS) Excel spreadsheet. The
standardized mean difference effect sizes, correlation coefficients, odds ratio and homogeneity
were computed using Excel and Statistical Package for Social Sciences (SPSS, version) Macros
programs.10
Despite the extensive literature retrieved related to diarrheal management, a high degree
of variability was noted between studies in terms of methodologies and designs, intervention and
study population. Statistically significant heterogeneity was detected (Q = 87.70, p = 6.83x 1021
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); which does not allow for combining of the studies’ findings for further analyses. As

illustrated in Table 1, the nature of reported outcomes differed from one publication to the other.
Therefore, the authors moved on to completing an integrative review of the literature following
the PRISMA guideline to further delineate the study findings.11 The review focused on
describing the results of observational studies describing the prescription of ORT in the
management of childhood diarrhea in children under 15 years old by health professionals with
formal and informal health training in South Asia.
2.3 Results
2.3.1 Study characteristics
The literature search yielded 4442 articles from the different databases and reference
lists. Of those articles, 2917 were excluded after removing duplicates and articles published in
non- English language outside of the study period. Titles and abstracts of 1525 articles were
screened for the initial eligibility criteria. Limiting the review to South Asia and study design and
methodology, 1433 articles were excluded and 92 articles were identified for full article review
by two co-authors. Based on the review and discussion, 74 did not meet the additional eligibility
criteria mainly because they did not separate prescription practices based on the healthcare
providers’ groups. In total, 18 articles were included in the analysis after limiting the eligibility
criteria to medical doctor and/or pharmacists. See PRISMA Diagram for details of study
selection process (Figure 1).
Of the 18 studies, seven were published before 2004 and 50% were studies performed in
India (n = 9). In six articles, the study’s method and design was not specified while nine were
surveys. Respondents in the majority of the studies (n = 10) were medical doctors and/or
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pharmacists and their prescribing behaviors while the remaining studies focus on children
suffering of diarrhea and their caregivers’ reports. The age of the children varied with majority
referencing children under the age of 5 years. The definition and lengths of reported episodes of
diarrhea also differed within the sample. The reported period of diarrhea episodes varied from
diarrhea within the past 24 hours to the last diarrhea episode.
2.3.2 ORT prescriptions during management of childhood diarrhea
Before publication of 2004 WHO Guidelines. A majority of the findings of studies published
before 2004 (5 out of 7) reported healthcare providers’ prescriptions of any ORT tended to be
higher than 50% .12-17 Depending on the sample sizes of these studies, percentages of any ORT
prescribed to children ranged between 60 % to 94.6% .15,18 Rarely did the studies report the
prescription of ORT alone. The highest percentage of ORT prescriptions were reported when
prescribed in combination with other medications, mainly antibiotics. Only three studies
mentioned ORT formulation recommended by the WHO.
Medical doctors were reported to prescribe higher rates of any ORT compared to
pharmacists.12-14,17 For example, Raghu and colleagues (1995) evaluated the awareness and
attitude of medical doctors and pharmacists in India toward oral rehydration therapy for the
treatment of diarrhea in children within a survey study and found that 77% (n = 53) of medical
doctors reported prescribing ORT compared to 59% of pharmacists who declared prescribing
ORT.14 The authors also reported that only one pharmacist in the study prescribed ORT using the
WHO recommended formulation compared to 48% of pharmacists who prescribed ORT
formulations that were not compliant with the WHO recommendation.14
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After publication of the 2004 WHO guideline. More variability in ORT prescription rates was
noted in studies published after the 2004 WHO guideline on the management of childhood
diarrhea.19-22 Depending on the study design, sample population and sample size, ORT
prescription rates varied between 2.4 % and 100%.22,23 In a prospective observational study
auditing the prescriptions rates of doctors treating children between the age of 6 months and 5
years in an Indian tertiary care hospital, ORT and zinc were reported to be prescribed in
accordance with the 2004 WHO protocol in all cases of children suffering from diarrhea.23
However, the authors also reported that among the 402 children who were prescribed additional
medications for the treatment of diarrhea, deviation from the WHO protocol was noted in 78.4%
of the cases.23 In other words, more than two thirds of the children who were treated by medical
doctors, were prescribed additional medications not recommended by the WHO guideline during
the management of the child’s diarrheal episode.
Similar to the studies published before 2004, studies examining the practices of
pharmacists with formal and informal training tended to report lower rates of ORT prescriptions
then what was recommended by WHO guidelines.14,22 Diwan and colleagues used a simulated
client survey to assess the treatment of childhood diarrhea in private pharmacies in the province
of Madhya Pradesh, India.22 Of the 164 private pharmacists surveyed using a questionnaire with
a simulation of a visit with a child suffering from diarrhea and their caregiver, only four
prescribed ORT.22 Antibiotics, however, were prescribed by 40.24% (n = 66) pharmacies and
anti-motility drugs were prescribed by 31.1% (n = 51) of pharmacists.22 It was also noted that
ORT is cheaper and thus less, profitable for pharmacists to prescribe.
Several other studies also reported on the significant number of prescriptions of other
medications mainly antibiotics, anti-motility and probiotics drugs for the treatment of diarrheal
24

episodes. The WHO guideline has been published for more than a decade, yet, findings from the
most recent study included in this review (published in 2016) indicate that antibiotics were
unnecessarily prescribed in 12.2% of the cases and probiotics were prescribed in 78.1% of the
cases of children with diarrhea (n = ,406).23
2.4 Discussion
The findings of the present study indicate that numerous observational studies have
reported on healthcare providers’ management of childhood diarrhea. However, prescription
rates varied significantly across the selected studies based on the population, study’s method and
design as well as the type of data collected.
A systematic review of the selected studies suggest that ORT was mainly prescribed in
conjunction with other drugs. ORT was seldom prescribe alone and was not the first-line of
intervention. In addition, the findings also indicated more variability in ORT prescription
practices in the management of childhood diarrhea in the studies published after 2004 compared
to those published before the 2004 WHO guideline. The overall limited rate of ORT prescription
and wide disparity in ORT coverage was associated with healthcare professional training.
Consistently pharmacists and/or pharmacy personnel were reported to prescribe lower rates of
ORT compared to medical doctors and/or health facilities workers.
These findings are consistent with a previous review on childhood diarrhea treatment
coverage at the global and regional level.24 These authors stated that following the success of
diarrhea management focusing on ORT usage in the 1990’s, the adherence to the 2004 WHO
guidelines on the management of childhood diarrhea has been “extremely slow” and even
“stagnant”.24 Low use of ORT has been associated with certain factors such as healthcare
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providers’ knowledge and perception of the severity of the diarrhea episode, parents’ expectation
and the financial profit to sell more expensive therapies.25 Each of the factors has been reported
to influence the use of ORT and increase prescription of antibiotics and other drugs. Efforts must
be made to improve national policies encouraging healthcare providers’ education, increasing
community awareness, large scale manufacturing, and increase awareness and demand for ORT
in the treatment of childhood diarrhea.
2.4.1 Limitations
Given the variability of the study designs, methodology, and population, findings from
the studies could not be combined and extrapolated. This is indicative of the lack of consistency
in research methodology of published studies. While mentioned in three studies, the review did
not include research evaluating the care provided by traditional healers or community health
workers, who play significant roles within communities in this region of the world. However, a
systematic review reveals trends in ORT prescription that are consistent with previously
published reviews and with the United Nation’s current published data.
2.4.2 Implication for research
A significant amount of evidence exists on the cost-effectiveness of ORT in diarrhea
control programs, the findings suggest the need for more studies evaluating the actual prescribing
behaviors of health providers during management of childhood diarrhea. This type of evaluation
will offer important insight on the effectiveness and sustainability of already existing programs
as well as identifying local and regional issues and barriers hindering the prescription of ORT by
health providers in South Asia. This integrative review uncovers the need for observational
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studies using more rigorous and standardized methodology to evaluate the overall prescription
rates of ORT in the management of childhood diarrhea in South Asia.
While the WHO guideline has been used to formulate national policies, the studies
suggest the need to evaluate healthcare providers’ education and adherence to the WHO
guideline and impact of the unnecessary use of antibiotics. Since prescription of the known
strategies have been stagnant for the past 40 years, it is evident that the current training programs
should incorporate a more sustainable message. These health education strategies must address
the cultural norms of a given community and include ongoing re-assessment and education
sessions.
2.5 Conclusion
With one of the highest rates of childhood diarrhea worldwide, South Asia remains the
region of the world with the second lowest usage of ORT. While the evidence from a metaanalysis cannot be combined, a systematic review of the selected articles reveals a trend that is
consistent with already existing data in other regions of the world. Despite the publication of the
2004 WHO guideline and the strong published research evidence on the cost effectiveness of
ORT, observational study findings indicate that ORT is prescribed in low rates and inconsistently
by medical doctors and pharmacists with formal and informal training. Allocating more
investment in studies with stronger methodology will allow a more accurate evaluation of the
medical doctors and pharmacists prescriptions of ORT in the management of childhood diarrhea.
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Figure 1. Studies Selection Process
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Table 1. Characteristics of Included Studies
Authors/ Year/
Country

Study design, study
objectives

Study population/
Number of
participants

Intervention

Use of
WHO
guidelines

Proportion of ORT
prescriptions

Gani et al., 1991.
Indonesia

Design not specified
To investigate both
reported and observed
prescribing practices
for treatment of acute
diarrhea in children
under 5 years of age

122 physicians
participated in survey
73 physicians
participated in
observational study

Survey interview,
observations of
physicians' clinical
practices and an
in- depth
interview.

None

ORT prescriptions
by physicians :70%
reported
67% observed
physicians

Kasi et al., 1995.
Pakistan

Design not specified
To screen the practices
of a small sample of
doctors confronted
with children with
diarrhea

30 doctors

Each survey team
member
introduced herself
as the mother of
the infant, and
stated only that
the child had
diarrhoea.

None

Prescription of
ORT by doctors:
60%

Raghu et al., 1995.
India

Design not specified
To evaluate the
awareness and practice
of oral rehydration
therapy amongst
mothers, medical
practitioners and
pharmacists.

48 medical
practitioners, 56
pharmacists and 55
mothers of children
with diarrhoea

Interviews using a
prepared
questionnaire

WHO

Nizami et al., 1996.
Pakistan

Design and objective
not clearly stated

996 children with
diarrhea

Observation of
encounters
between children
with diarrhea and
general
practitioners (n =
62) and
pediatricians (n =
28)

None

ORT prescriptions:
by pharmacists:
WHO formulation
(n = 1; 1.7%); nonWHO formulation
(n = 27; % =
48%).
By doctors: WHO
formulation (n = 8;
%16.5); Non Who
formulation (n =
29; % = 60.5)
ORT prescription
per qualification:
general
practitioners:
53.2%;
pediatricians:
60.7%

Buch & Bashir,
1997. India

Design not specified
To focus on the
inadequacies in the
current management
practices of acute
diarrhea

1030 infants with
acute diarrhea

Information
regarding nature
of diarrhea and its
management were
collected from the
details mentioned
in the prescriptions
of the infants

None
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ORT/SSS
prescriptions:
4.1% of infants
treated at private
clinics and health
units

Proportion of
prescription of
therapies other
than ORT
Antibiotics
prescriptions by
physicians:
61% of physicians
94% of observed
physicians
Mixture of kaolin
and pectin: 46%
Other drugs: 80%

Antibacterials:
50% of
pediatricians
Antidiarrhoeals:
60% general
practitioners and
28% pediatricians
Antiamoebic: 39%
of general
practitioners,32%
of pediatricians
Antidiarrheal +
antispasmodic
drugs: 46.8% of
infants treated at
private clinic or
health units
Parenteral
antibiotics: 11.3%
of infants

Choudry et al.,
1997. Pakistan

Survey
To study the current
practices and factors
affecting the
management of acute
watery diarrhea in
children below 5 years
of age

262 general
physicians

Physicians were
interviewed at
their place of work
by a team of three
physicians using a
pretested, semistructured
questionnaire

Yes

ORT alone by
physicians: 19%.
ORT + drugs: 61%

Prescriptions of
drugs alone: 15%

Howteerakul et al.,
2003. Thailand

Design not specified
To explore Thai
physicians’ rationales
about their prescribing
practices for treating
childhood diarrhoea

424 cases of child
diarrhea

A clinical audit and
observations of
424 cases treated
by 38 physicians
used to estimate
the prevalence of
sub-optimal
prescribing
practices.

Yes

ORT prescriptions:
91.3% of child
cases

Antimicrobial:
75.5% of child
cases
Antiemectics +
Antispasmodic:
32.4% of child
cases
ORT+ other
drugs/IV:94.6% f
child cases

Ahmed et al.,
2009. India

Cross sectional survey
To study the treatment
practices of diarrhea
and symptoms at
health facilities
(medical practitioners)

1052 children under
5

None

ORT only: 8.7% of
children treated at
the health
facilities

Antibiotics: 77.9%
of children treated
at health facilities

Saengcharoena et
al., 2010. Thailand

Simulated client survey
To compare practice
behavior and attitudes
of pharmacy personnel
in the management of
childhood diarrhea
Design not specified
To determine the
prescribing practices of
doctors in
management of acute
diarrhea in children.

63 Pharmacists

Household survey
visits were
conducted at the
end of each season
and details
regarding any
current episode of
diarrhea and any
past episodes of
diarrhea were
recorded from the
mother
simulated client
survey and
questionnaire
survey

None

ORT prescriptions:
4.2% of
pharmacists

Antibiotics: 25.2%
of pharmacists

388 children suffering
from acute diarrhea

Not specified

IAP
guideline

ORT prescriptions
by doctors: 90.2%

Antibiotics: 82.5%
Pro/prebiotics:
56.4%
Antiemectics: 43%

Prescriptions chart
review
To determine the levels
of adherence to
treatment guidelines
for acute diarrhea in
children up to 12 years
seen in drug
prescriptions

843 prescriptions

Pharmacy
assistants and
medical officers
assisted in the
collection of
information from
outpatient
prescriptions

None

ORT alone: 58%
of reviewed
prescriptions

Antibiotics: 71% of
reviewed
prescriptions

Chakraborti et al.,
2011. India

Pathak et al., 2011.
India
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Aung et al., 2013.
Myannmar

Survey study
To determine the
norms for both homebased care and healthseeking behavior

253 children under 5

A structured
questionnaire was
administered by
trained healthcare
workers.

Yes

Pham et al., 2013.
Vietnam

Pre intervention
survey.
To report knowledge
and practice of staff in
pharmacy settings
regarding management
of childhood diarrhea
Cross-sectional study
using interviews
To asses diarrhearelated knowledge,
practice, their
correlates and
interrelationship
among allopathic
practitioners treating
diarrhea patients in the
slums of Kolkata
Cross-sectional survey
To appraise
general practitioners i
n the management
of acute
watery diarrhea for
children under 5 years
of age

220 pharmacies
281 pharmacy staff

survey was used to
record knowledge
and reported
practice and
simulated client
surveys

None

264 practitioners

Interviews
collected on
practitioners'
knowledge
attachment, year
of practice,
average age

None

Prescription of
ORT: Odds Ratio =
1.24 of qualified
and government
physicians

Antibiotics:
49.24% of
physicians

380 general
practitioners

Semi structured
questionnaires
assessing the
knowledge and
practices regarding
the management
of acute watery
diarrhea

Yes

Prescription ORT
based on general
practitioners’
qualification:
MBBS only 48.1%.
MBBS and Minor
diploma
pediatrics: 100%

Antidiarrheal
drugs: MBBS
74.4%
MBBS + minor
diploma in
pediatrics: 100%

Diwan et al., 2015.
India

Cross-sectional study
using simulated client
survey
To assess the
treatment of childhood
diarrhea in private
pharmacies

164 private
pharmacies

Yes

ORT prescribed:
2.44% pharmacies

Antibiotics:
40.24% by
pharmacies
Anti-motility drug:
31.1% by
pharmacies

De et al., 2016.
India

Prospective
observation: Audit of
prescriptions
To study the
prescription practices,
regarding adherence to
WHO protocol and
deviations in the
management of acute
diarrhea in children

402 children 6
months- 5 years with
acute diarrhea
episode

Four simulated
clients visited the
pharmacies and
filled out a
questionnaire
within 15 minutes
after leaving the
pharmacy.
Cases were
evaluated in detail
for clinical history,
physical
examination,
prescription given
by treating doctor
at the hospital and
associated comorbidity. Each
prescription was
scrutinized to

Yes

ORT: 100% of
cases

Probiotics: 78.1%
of the cases
Antibiotics: 12.2%
of the cases

Kanungo et al.,
2014. India

Naeem et al.,
2014. Pakistan
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Any ORT:
Government
health facilities:
16.6% of infants
Private providers:
13.4%
Pharmacy: 0.8%
Any ORT
prescriptions:
41.9% of
pharmacists and
pharmacy staff

Antibiotics: 14.8%
of pharmacists
and pharmacy
staff

determine
whether WHO
protocol was
followed or not

Fisher Walker et a.,
2016. India

Survey using: Interview
and direct observation
To characterize the
childhood diarrhea
treatment knowledge
and practice of both
formal and informal
private sector
providers

232 private providers

Interviews and
direct observation
conducted on
diarrhea treatment
knowledge and
practice and access
to ORS and zinc
supplies
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Yes

Interviews: ORT
prescription:
68.1%
Direct
observations:ORT
prescriptions:
56.7%

Antibiotics: 65.9%
Zinc: 35.8%.
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What is known:
Even in the developed country like the United States, diarrhea associated infections remain a
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has been proven to provide optimal immunity to prevent diarrheal infections.
What this study adds:
Breastfeeding cessation prior to six months of age significantly increases the risk of having a
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Abstract
Background: Diarrhea diseases remain a major cause of childhood morbidity in the United
States. Optimal breastfeeding has been identified as one of the most effective measure to prevent
diarrhea diseases in childhood.
Objective: To evaluate the impact of breastfeeding duration during the first 6 months of age on
the incidence of diarrhea in infants between 7 and 12 months in the United States.
Methods: A secondary data analysis was performed using mothers and infants participating in
the Infant Feeding Practices Study II (2005-2007).
Results: Compared to those who breastfed for 6 months or more, infants who discontinued
breastfeeding between 0 and 3 months were at 48.4% greater risk to have diarrhea at 7 and 12
months and those who discontinued breastfeeding between 3 and 6 months were at 31% greater
risk of having diarrhea between 7 and 12 months.
Conclusion: Breastfeeding cessation before the first 6 months is a significant predictor of
diarrhea between 7 and 12 months.

Word count: 2989
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3.1 Introduction
The major burden of diarrheal related morbidity and mortality is reported to be in the
developing regions of the world. However, children living in richer countries are also affected by
diarrheal diseases.4 While accounting for fewer deaths in developed countries, diarrheal
infections are associated with high rates of doctors and emergency hospital visits, hospital
admissions and medical costs. In the US, diarrheal related infections account for approximately
300 deaths each year in children under the age of 5.4
Causing approximately 200, 000 hospitalizations, it is estimated that diarrhea cost about
$250 million in direct medical expenses each year.4-5 Low birth weight, being male and black are
all factors that have been found to significantly increase the risks of dying from diarrheal
diseases in the US.6 Preventive measures to control and reduce the impact of diarrhea in the US
includes the promotion of rotavirus vaccines and optimal breastfeeding for the first 6 months of
life are among the key strategies to prevent diarrhea.5
Before the introduction of rotavirus vaccines, the pathogen was reported to cause the
most frequent episodes of diarrhea in US children with 55,000 to 70,000 hospital admissions
each year and approximately $1 billion to the US government in medical cost.7 Following its
introduction between 2007 and 2009, the rotavirus vaccine was estimated to reduce
gastroenteritis hospitalizations by at least 53% in US infants living in the Western part of the
country.7 The vaccine reduced by more than 70% diarrheal related infections among children
between 1 to 4 years old in the Southern, Northeastern and Midwest regions of the US.7 Besides
the rotavirus vaccine, the promotion of breastfeeding for the first 6 months of life has been
another cost-effective preventive measure against diarrheal diseases in the US.
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Since 1984, breastfeeding was identified as one of the most important and cost-effective
intervention, significantly reducing the incidence of infectious diseases among children
worldwide, especially diarrhea and pneumonia.4-6 Human breastmilk contains bioactive
molecules mostly secretory antibodies, lactoferrin and glycans offering protection and
maturation of the gastrointestinal track and immune system during infancy and early childhood.78

However, the 2014 CDC report card on breastfeeding indicates that only 18.8% of US infants

are exclusively breastfed at 6 months while 49.4% receive some breastmilk through 6 months.9
These numbers depict the perpetuation of suboptimal breastfeeding in the US since they remain
far from the Healthy People 2020 objectives of 25.5% exclusive breastfeeding at 6 months and
60.6% infants receiving some breastmilk at 6 months.9-11
In the most recent meta-analysis on breastfeeding practices published in the Lancet, it
was reported that compared to middle-income and low-income countries, the prevalence of any
breastfeeding at 12 months is lower in high-income countries.17 The weighted prevalence of
breastfeeding at 6 months in high income countries was approximately 45% (compared to more
than 95% in low income countries) and was 20% at 12 months (compared to more than 90% in
low income countries).17 Breastfeeding practices among US mothers are not an exception. The
prevalence of any breastfeeding at 12 months in the US is around 27%.17
While the protective effect of breast milk is undeniable, significant gaps still exist in the
promotion and practice of early breastfeeding initiation and continuation for the first 6 months of
life, even in countries like the US. Non-exclusive or early interruption of breastfeeding, also
known as suboptimal breastfeeding, was ranked in 2010 by the Global Burden of Disease Study
as the second leading risk factor of disease burden in children under the age of 5 worldwide
regardless of whether the child was in a developed or under-developed country.18
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The prevention of persistent diarrhea through the promotion of optimal breastfeeding is
imperative in reducing the burden of the symptom in early infancy and childhood. Thus
providing more evidence on the outcomes related to the immunologic properties of breastfeeding
using a national survey database, will strengthen the empirical evidence and encourage the
promotion of optimal breastfeeding practices of US mothers. The Infant Feeding Practice Survey
II (IFPS II) dataset was utilized as it is the most recent survey that compiled comprehensive
information on US mothers and infant feeding practices and their associated health status.12 By
our best knowledge, this is the first study to examine the IFPS II data to assess the longitudinal
effect of breastfeeding duration on the occurrence of diarrhea.13
The goal of this study was to evaluate the impact of breastfeeding duration during the
first 6 months after birth, on the maternal reports of diarrhea episodes in infants during their first
year of life. You could add research questions/hypotheses here. A secondary data analysis was
performed to answer the following research question: Is the incidence of diarrhea episodes in
infants between the ages of 7 to 12 months influenced by mothers' breastfeeding duration
between 0 to 6 months? The research question was based on the hypothesis that compared to
infants who discontinued breastfeeding between 0 and 6 months, the infants who were breastfed
up to 6 months or longer would have a lower count of diarrheal episodes, reported by mothers
within 2 weeks prior to completion of questionnaires at 7, 9, 10, and 12 months.
3.2 Patients and Methods
A secondary data analysis method was used to in evaluate the effect of breastfeeding
duration during the first 6 months of life on the reported incidence of diarrhea in infants between
the ages of 7 and 12 months. The study population included mothers and their infants enrolled in
the IFPS II. Longitudinal data was collected between May 2005 and June 2007 on a nationwide
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consumer opinion panel of 4902 women who were at least 18 years old, in their third trimester of
pregnancy and expecting a singleton birth.12
Mothers were excluded from the study if: they refused to participate; did not return the
questionnaire; the infant was born before 36 weeks gestational age; the infant was born with a
long-term illness. Mothers were also excluded from the original study if they resided in areas
where the United States Postal Service could not deliver mail after the 2005 Gulf Coast
hurricanes.12 Based on these exclusion criteria, a total of 3033 mothers completed all the survey
questionnaires.12
3.2.1 Participants
The sample size was limited to mothers who completed the questionnaires with reports
on breastfeeding cessation, last time a questionnaire was retuned and diarrhea episodes between
7 and 12 months after delivery. We excluded data missing study variables (no survey responses
reported) on the study’s variables. A total sample of 2344 dyads (mother/infant) were included in
the final analysis (Figure 1).
3.2.2 Study variables
Breastfeeding duration. Breastfeeding duration was the primary exposure variable and
corresponds to the infant’s age when the mother reported to completely discontinue
breastfeeding and provision of expressed breastmilk. The variable indicates the infant’s age
when he/she stopped receiving breastmilk either directly from the breast or expressed (pumped).
The variable was categorized into four subset variables: 1) infants reported to have never
breastfed (bfduratn= 0); 2) infants who stopped receiving breast milk between 0 and 3 months
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(0.1 to 12.0 weeks); 3) infants who stopped receiving breast milk between 3 and 6 months (12.1
to 23 weeks); and 4) infants who receiving breast milk at 6 month or beyond (≥ 24 weeks?).
A variable, last questionnaire received, was created to identify the number of mothers
who dropped out before the 6 month study period. The last questionnaire received was coded the
last time (in month), mothers were reported to return an IFPS II questionnaire. The code allowed
estimation of the number of mothers who discontinued breastfeeding between 0 and 6 months
after delivery. This variable was also used to estimate the sample size of each breastfeeding
duration groups.
Reported episodes of diarrhea. The main outcome variable was reported diarrheal episodes
within the 2 weeks prior to receiving the questionnaire at 7, 9, 10 and 12 month of infant age.
Data on infants’ diarrheal episodes were obtained on the questionnaire by asking the following
question: “Which of the following problems did your baby have during the past 2 weeks?”
Diarrhea was listed as one of the multiple choice options including fever, vomiting and ear
infection. The occurrence of a diarrheal episode was defined as a mother reporting at least one
episode of diarrhea within the 2 weeks prior to receiving questionnaires in months 7, 9, 10 and
12. For the purpose of the analysis, the dependent variable (reported episodes of diarrhea) was
recoded into a binary variable: 0 = no episodes of diarrhea; 1 = 1 or more episodes of diarrhea
reported at months 7, 9, 10 and 12.
A total of 59 mothers did not respond to the question on diarrhea at least once between
months 7 and 12 month questionnaires. A sensitivity analysis was completed to determine
whether treating the lack of response as occurrence (condition 1) or non-occurrence (condition 2)
of diarrhea would modify the study finding. No statistically significant difference were found.
The statistical analysis was completed using the more conservative condition, condition 1.
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Offset variable. The number of times a mother reported an episode of diarrhea between 7 and 12
months depended on the number of questionnaires she returned during that given period.
Therefore, the number of questionnaires returned by each mother could affect the total count of
reported diarrhea episodes. For this reason a variable “number of questionnaire returned” was
created to account for the total number of time mothers returned the survey questionnaire
between 7 and 12 months. A value from 0 to 4 was given based on the number of times a mother
returned a postnatal questionnaire at months 7, 9, 10 and 12. This variable was considered an
offset variable and was used as a control variable during statistical analysis using Poisson
regression.
Other variables. Following consultation with a certified lactation specialist and an extensive
literature review, a series of mother and infant characteristics were identified as potential
confounders were therefore controlled for in the Poisson regression. The variables included
sociodemographic characteristics of the mothers such as age, race, level of education and
employment status. Infant characteristics included gender, weight and occurrence/nonoccurrence of infant breastfeeding during the neonatal period.
3.2.3 Statistical Analysis
Frequency and descriptive statistics were completed for the demographic characteristics
of the sample using SPSS version 22.14 To assess the association between breastfeeding cessation
and the report of diarrhea episodes in a longitudinal manner, generalized linear modeling using
Poisson regression was used. Recoding of the variables of interest was completed using SAS
version 9.4.13
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Diarrhea episodes were self-reported by the participating mothers and returns of the
questionnaires occurred at different times for each participants; so these variables could not be
controlled. For these reasons, rate ratios rather than relative risk were conducted to estimate the
possible relationship between the independent and dependent variables. Poisson regression was
applied to estimate the rate ratio (RR) and a p value was obtained based on the Wald test and
95% confidence interval of the reported occurrence of diarrhea between months 7 and 12 as it
related to breastfeeding cessation between 0 and 6 months. All analyses were completed using
SPSS version 22.15
3.3 Results
3.3.1 Participants’ demographics
Demographic statistics for maternal and infant characteristics are presented in Table 1. In
the infant cohort, the male to female ratio was almost equal with 49.7% male and 50.2% female.
A majority of the infants were delivered vaginally (71.3%) with an average birth weight of 7.64
pounds. Descriptive analysis of the maternal participants indicated that mothers’ average age was
29 years old with the majority being White (85.5%) and married (77.4%). Most mothers were
highly educated (65% had some college education) and 45% lived in a household with an income
level higher than $50,000. Maternal and infant characteristics in this cohort mirror the larger
IFPS II sample of 3033 mother- infant dyads. A majority of the mothers in the initial IFPS II
study were White (84.4%), between 25 to 34 years old (61.4%) with a college education
(40.2%).12
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3.3.2 Breastfeeding duration and reported episodes of diarrhea
Of the 2344 mothers included in this study, 84.3% (n= 2000) either breastfed or tried
breastfeeding their infant during the neonatal period. More than a quarter of the infants (25.8%)
stopped receiving any breastmilk before 3 months. In this study, 14.2% of the infants were never
breastfed either directly from the breast or expressed breastmilk from the bottle; while 38.5%
stopped being breastfed between 0 and 6 months. A total of 1109 (47.3%) infants were
reportedly breastfed for the first 6 months or more. Approximately 28% of the mothers reported
one or more episodes of diarrhea within the last 2 weeks after receiving questionnaires in months
7, 9, 10 and 12. The reported episodes of diarrhea increased over time with 6.4% mothers
reporting at least one episode at 7 months compared to 12% reported at least one episode at 12
months.
The incidence of diarrhea for infants who breastfed for 6 months or more was
approximately 93 per 1000 infants (p = 0.000). The results from the Poisson regression model
that assessed the relationship between the four-level breastfeeding cessation variable and
reported episodes of diarrhea are described in Table 2. Repetition of the analysis using either
condition 1 (considering “no answer on diarrhea occurrence question” as no occurrence of
diarrhea) or condition 2 (considering “no answer on diarrhea occurrence question” as occurrence
of diarrhea) did not change the rate ratio for breastfeeding cessation. Further analyses were
completed using the more conservative approach, condition 1.
Breastfeeding cessation during the first 6 months of life is a significant factor predicting
the number of reported episodes of diarrhea between 7 and 12 months. Compared to the infants
who breastfed for 6 months or more, infants who discontinued breastfeeding between 0 and 3
months were at 48.4% greater percentage to have a reported episode of diarrhea at least once
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between 7 and 12 months (p = 0.000 CI [1.18- 1.71]). Infants who stopped receiving any
breastmilk between 3 and 6 months were at 31.1% greater risk of having a diarrhea episode
reported by their mother between 7 and 12 months (p = 0.016, CI [1.17- 1.90]) compared to
those who breastfed for 6 months or more.
When adjusting for the demographic variables by entering them as covariates in the
Poisson regression modeling, the results indicate three maternal characteristics significantly
affected reported episodes of diarrhea. These variables were household income, maternal age,
and maternal education level. Among the mothers who breastfed their infants, every $1,000
increase in their household income was linked to a 2% decrease in reported episodes of diarrhea
at months 7, 9, 10 and 12 (p = 0.006). The results also showed that reported episodes of diarrhea
decreased with older (RR = .98; p = 0.000) and more educated (RR= .92; p = 0.02) mothers
(Table 2).
In addition, none of the reported infant demographic characteristics were found to
significantly influence the reported episodes of diarrhea between 7 and 12 months. When infant
birth weight was added as a covariate in the regression model, the estimate rate ratio was .970 (p
= .367). Gender or delivery method also did not show a statistical significant impact on the
relationship between breastfeeding duration and report of diarrhea episodes (p = .143 and p=
.684 respectively). In other words, inclusion or exclusion of the infants’ demographic variables
in the regression model did not change the rate ratio estimates of reported episodes of diarrhea
between 7 and 12 months based on breastfeeding duration before the age of 6 months.
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3.4 Discussion
Breastfeeding is considered the most cost effective intervention to assist in preventing
diarrhea in early infancy and childhood. In a 2011 meta-analysis of studies performed in
developing countries between 1980 and 2009, Lamberti et al., reported that no breastfeeding
increased by 26% the risk of incidence of diarrhea in infants between the ages 0 to 5 months.16
While exclusive breastfeeding is the recommended practice for infants up to 6 months of age, the
authors reported that any breastfeeding for more than 6 months had a protective effect on
outcomes such as diarrhea. Increasing evidence indicates that antibodies and glycobiome found
in breastmilk provide an important source of protection against infectious diseases.15 These
breastmilk components are reported to provide protection against diarrhea by decreasing the
incidence and duration of diarrheal episodes.16
Consistent with the previous research, the present study demonstrates that breastfeeding
for 6 months or more could significantly decrease the incidence of diarrhea for infants younger
than 12 months. The results of the secondary data analysis indicated that approximately 93 in
1000 infants who breastfed for 6 months or more had at least one episode of diarrhea reported by
their mothers between 7 and 12 months. The number of infants experiencing an episode of
diarrhea increased by 48.4% if they stopped receiving breastmilk before 3 months and by 31.1%
if they stopped receiving any breastmilk between the first 3 to 6 months of life. The findings
showed that infants who breastfed for less than 3 months had the highest risk of diarrhea prior to
12 months of age.
This could be due to the decrease in breastfeeding intensity and introduction of solid
foods. In a previous secondary analysis of the IFPSII, Grummer-Strawnn et al. (2008) reported
that by 3 months, majority of the infants (80%) were either fed breastmilk or formula milk. By 4
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and 5 months, 61% of the infants were fed with formula.36 Supplementation and early
introduction of food other than breastmilk have been linked with suboptimal breastfeed and
increase likelihood of infections like diarrhea- related diseases.14
When adjusting for mothers’ age, education and household income, breastfeeding
duration was significantly associated with reported episodes of diarrhea. Adding each of these
variables individually in the regression model was associated with variation in the event of
having a reported episode of diarrhea varied statistically significantly. Higher income households
decreased the likelihood of reporting an episode of diarrhea by 2%. Infants whose mothers had a
higher level of education decreased the risk of reporting an episode of diarrhea by 8%. These
results are consistent with previous research and publications reporting that higher income and
more educated mothers tend to breastfeed longer and thus, have healthier infants with less risks
of diarrheal symptoms.37-40
Jones et al, assessed the factors associated with breastfeeding practices in US infants
using the 2007 National Survey of Children’s Health. The authors reported that children living in
families with a household poverty status between 200% and 399% of the federal poverty level
were 85% less likely to ever breastfeed compared to their counterparts living in household with a
poverty level higher than 400% the federal poverty level.37 In addition, the authors also found
that 20 years old or younger mothers are .88 times less likely to ever breastfeed compare to 30
years old or older mothers.37 Results from Jones’ study and the present study reflect the 2011
“Surgeon General’s Call to Action to Support Breastfeeding”, the US Department of Health and
Human Services noted the significant disparities in breastfeeding based on race and ethnicity,
socioeconomic characteristics and geographical location.41

49

This study is the first to explore a longitudinal relationship between breastfeeding
duration and diarrhea episodes using the IFPSII dataset. The use of a more recent database to
explore the protective effect of breastfeeding strengthens the literature and provides more
evidence toward the promotion of breastfeeding in early infancy at the clinical practice and
community level.
3.4.1 Limitations
While consistent with the current literature, the results are subject to certain limitations.
Because the IFPS-II dataset is derived from a self-selected costumer opinion panel rather than
random sampling, it is not a necessarily representative sample of the US population.
Participating mothers were predominantly white, medium to high income with higher level of
education. Therefore, the study findings cannot be generalized to the entire US population.
Second, breastfeeding cessation was a composite variable that did not distinguish
between infants who exclusively breastfed and those who partially breastfed. Had these items
been available in more precise variables it may would have allowed the formulation of a stronger
relationship between exclusive breastfeeding duration and the occurrence of diarrhea. More
specific information on the breastfeeding type may have also allowed for exploration in the
differences between the effects of exclusive versus any breastfeeding duration on reported onset
of diarrhea episodes.
Thirdly, the code 77, which represented both mothers who dropped out during the study
and those who continued breastfeeding beyond the study period, did not allow a clear distinction
between the mothers who dropped out early during the study and when did they drop out versus
the mothers who continued breastfeeding beyond the 12 months study period. Finally, the lack of
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data collected between the neonatal period and month 3 was a missed opportunity to depict a
clearer picture of early breastfeeding cessation and potential influencing factors. Additionally,
the reported episodes of diarrhea were self-reported by the mothers, so the definition of diarrhea
might have varied based on mothers’ knowledge and perception.
3.4.2 Implication for practice and research
The study’s findings support US and WHO clinical practice guidelines regarding
breastfeeding during infancy. The results also highlight the issue of suboptimal breastfeeding
during the first 6 months of life and its impact on the increased incidence of diarrhea later during
the first year of life. By providing statistically significant evidence in the protective effect of
breastfeeding duration for 6 months or more, the study adds to the existing research and
evidence-based policies for the promotion of optimal breastfeeding at the clinical and community
level.
While already established and practiced, these strategies need to be re-evaluated to
identify and address the factors influencing limited adherence to optimal breastfeeding during
this critical period in infancy. The study sample did not include additional minority groups.
Therefore, further studies using a prospective longitudinal design must be done to better capture
breastfeeding cessation and diarrhea incidence across a nationally representative sample thereby
reflecting the racial/ethnic and economic diversity of the US population.
3.5 Conclusion
Diarrhea related infections remain an issue for children under the age of 5 years
worldwide. Optimal breastfeeding for at least the first 6 months of life has been considered one
of the most effective interventions for protecting infants against diarrhea. The findings from the
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present secondary data analysis using a nationwide dataset provides more evidence for the
protective effect of breastfeeding against diarrhea. While this has been well-known for the last
three decades, adherence to optimal breastfeeding for the first 6 months of life remains limited,
even in more developed countries like the US and within a subgroup of the population with
higher income, education level and better access to healthcare services and support. Further
research leading to evidence based health promotion programs are warranted to identify and
address factors predicting early breastfeeding cessation. Additionally, these programs need to
offer healthcare providers the means to detect early in the post-partum period (during
hospitalization) and follow-up periods, mothers at-risk for suboptimal breastfeeding practices to
offer the best protection against diarrhea illnesses.
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Table 1 Maternal and Infants Demographics
Total N= 2344 (%)
Mother’s Characteristics
Race
White
Black
Asian/Pacific Islander
Other/Missing

2003 (85.5)
89 (3.8)
64 (2.7)
188 (8.0)

Age (averaging years )
18 - 28
29 - 39
40 or older

1092 (46.5)
1158 (49.4)
94 (4.1)

Marital status
Married
Unmarried
Missing
Household Income (US dollars)
less than 5000
5000-24999
25000- 49999
50000-74999
75000-99999
100000 or over
Education Level
High-school or less
Some college
College graduate or higher
Missing
Employment status
Full time
Part time
Unemployed/missing

1811 (77.3)
402 (17.2)
131 (5.6)
47 (2.0)
428 (18.3)
819 (34.9)
591 (25.2)
271 (11.6)
188 (8.1)
435 (18.6)
827 (35.3)
940 (40.1)
142 (6.1)
864 (37)
271 (11.6)
1209 (52)
Infant’s characteristics

Sex
Male
Female
Weight (average)
Delivery method
Vaginal
Cesarean section
Ever breastfed or tried breastfeeding
Yes
No

1165 (49.7)
1177 (50.2)
7.64 lbs
1671 (71.3)
673 (28.7)
2000 (85.3)
344 (14.7)
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Table 2 Effect of breastfeeding duration before 6 months and other variables on reported
episodes of diarrhea in months 7, 9, 10 and 12.
Parameter

Rate Ratio (RR) estimate for reported episode of diarrhea
RR (p value)

Intercept

0.093 (.000)

95% CI
[0.083-0.103]

Breastfeeding cessation
Never breastfed
Breastfed between 0-3 months
Breastfed between 3-6 months

1.24 (.043)
1.48 (.000)
1.31 (.016)

[1.007 - 1.52]
[1.26 - 1.74]
[1.05 - 1.64]

Household income

.98 (.003)

[.97 - .99]

Mother’s age

.98 (0.000)

[.96 - .99]

.92 (.02)

[.86 – 0.99]

Education

Figure 1 Participants’ selection process
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Figure 2 Percentage of reported number of diarrhea episodes at 7,9,10 and 12 months based on
breastfeeding duration.
30
25
20
15
10
5
0
Never BF

Stop 0-3mo

Stop 3-6mo

Number of diarrhea episodes 1.00

Number of diarrhea episodes 2

Number of diarrhea episodes 3.00

Number of diarrhea episodes 4.00
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Abstract
Background: In limited resources countries, the diagnosis and management of diarrheal diseases
are mainly symptom based. A pathogen identification tool suited to resources limited settings
will enable accurate identification of diarrheagenic pathogens, thereby improving management
of diarrhea.
Method: This feasibility study aims to test the sensitivity of a point-of-care lateral flow assay
strip under two different environmental conditions to mimic temperate compared to a hot climate
to Specifically, the goal is to correctly detect potential diarrheagenic pathogens present in stool,
such as Escherichia coli, under two different temperatures (69°F and 91°F). Time before the
appearance of positive signals and color intensity of the signals at the test and control zones were
used for sensitivity and performance analysis.
Results: In the presence of target DNA bound with gold nanoparticle and detection probe
complex, interaction with the capture probe at the test zone produces a red signal observable by
the naked eyes. At 69°F, optimum color intensity of the red signal was detected at 10 minutes
with 10 and 25nM target DNA concentrations. At the 91°F, interaction with the capture probe at
the test zone produced light pink signal observable by the naked eyes after the first 5 minutes.
The signal was only observable at 10 and 25nM target DNA concentrations. Generalized linear
model regression suggests that for every 1nM increase in target DNA concentration, color
intensity of the signal decreased by 3.8% in pixel value.
Conclusion: The tool was able to positively detect the presence of Escherichia coli at different
concentrations in a 69°F environment. Further optimization may improve the tool’s sensitivity at
91°F. This is a step forward in the utilization of a Point-of-Care pathogen identification tool to be
reliable in resource-limited settings.
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4.1 Introduction
The diagnosis and management of diarrheal episodes are mainly based on physical
symptoms. Laboratory diagnostic tests are expensive, time consuming, require significant
training and are often not available in a timely way (Kotloff et al., 2013; Kaushik., 2016). The
diagnosis and treatment of diarrheal diseases, based solely on patient or caregiver reported
clinical symptoms, is often inaccurate, causes preventable medical complications and
unnecessary use of other therapies such as broad spectrum antibiotics. In addition, inpatient
hospitalization for unresolved diarrhea episode create a significant economic burden to the
household and healthcare system. The average medical cost of hospitalization for a household is
approximately $44 in Rwanda, $3 in India and $6 in Pakistan (Ngabo et al., 2016; Rheingans et
al., 2012).
Molecular diagnostic methods, mostly with polymerase chain reaction (PCR), are the
current gold standard tests for diagnosis of infectious diseases (Platts-Mills et al., 2012).
However, PCR equipment and reagents are expensive, require skilled personnel and are
subjected to amplification bias (Platts-Mills et al., 2012; Sjöling et al., 2015). Reliable and valid
diagnostics are fundamental to identify the causes of a disease, formulate appropriate treatment,
limit unnecessary use of antibiotics and reduce the disease burden. There is currently, a growing
interest to develop lateral flow assays (LFA) for Point-of-Care (POC) diagnostic tool relevant to
the realities of limited resources settings (Reid, Fidler, & Cooke, 2013; Wang et al., 2016).
These novel diagnostic platforms need to be developed to address the WHO seven
characteristics of POC test for low resources settings. Also known under the acronyms
ASSURED the POC tests must be affordable, sensitive, specific, user-friendly, rapid and robust,
equipment-free and deliverable to end users (Mabey, Peeling, Ustianowski, & Perkins, 2004;
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Dittrich et al., 2016).
Given the recommendations of the ASSURED criteria, the present study is a feasibility
study that aims to assess the sensitivity of a rapid, simple to use, diarrhea pathogen identification
tool. Climate variation has been associated with an increase relative risk of diarrhea diseases by
22-29%; mainly by adversely impacting the quality of water supply and increasing temperature
and rainfall worldwide (Kolstad & Johansson., 2011; Mellor et al., 2016). It is estimated that for
every 1 degree Celsius increase in temperature there is approximately a 7% increase in diarrhea
(Carlton, Woster, DeWitt, Goldstein, & Levy, 2016).
The tool was developed as a collaboration with the National Institutes of Health, National
Institute of Nursing Research and GoDx Inc. It consists of a paper-based, colorimetric LFA strip,
using nucleic acid detection. The aim of this feasibility study was to evaluate the ability of this
tool to positively detect potential diarrheagenic pathogen under simulated environment such as
hot temperatures. Since LFA are intended to be used in the field, in resources limited settings,
the strips may be affected by the surrounding environmental conditions. In addition, increasing
evidence suggests that environmental factor such as temperature, significantly affect the
sensitivity of LFA (Choi, 2016). The successful completion of this study is expected to result in
further optimization of a tool; allowing healthcare providers, to formulate better management of
diarrhea by accurate identification of diarrheagenic pathogens regardless of the surrounding
environmental condition.
4.2 Methods
4.2.1 Pathogen Identification Tool
The tool was developed as a collaboration with the National Institutes of Health, National
Institute of Nursing Research and GoDx Inc. It consists of a paper-based, colorimetric LFA strip,
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using nucleic acid detection. Nucleic acid detection provides critical genetic information in
detecting the presence of infectious pathogens, the diagnosis and treatment of genetic diseases
and cancers (Sun, Xianyu, & Jiang, 2014). Paper has many natural properties making it adequate
to use in resource-limited settings. The most important features include its ability to passively
transport fluids through capillary flow; it is made of cellulose making it compatible with various
biological samples; its white color allows contrast background for visible and colorimetric
readouts; it is cheap, thin and light, hence easy to transport and store (Zhao, Brook, & Li, 2008).
The major principle in LFA involves an interaction or hybridization of a single-stranded
target DNA region of commercial Escherichia coli (E. coli) with complementary capture probe
forming a double-stranded nucleic acid. The hybridization will produce a colorimetric signal and
allowing the detection of the bacteria target DNA. Gold nanoparticles (AuNP) are used as
colorimetric probes in the tool. The red predictable color change of AuNP aggregation provides a
platform for colorimetric detection using AuNP as signal label to trace hybridization of the target
DNA (Zhao, Ali, Aguirre, Brook, & Li, 2008).
The LFA strip is about 6.0 cm long and is made of: a glass fiber sample pad, a conjugate
pad loaded with gold nanoparticles and detection probe complex, a nitrocellulose membrane
containing a test zone and a control zone and a cellulose absorbent pad facilitating fluid flow.
Colorimetric responses at the test and control zones of the LFA strip indicates the presence of the
target DNA diarrhea pathogens. More details on the tool are mentioned in another publication.
4.2.2 Study procedure
Commercial E. coli (2011C- 3911) DNA target sequence was purchased and cultured in
100µl of broth to a final concentration of 100µM. Five different dilutions of the target DNA
solution were made in 4X SSC buffer. They included: 1nM, 10nM, 25nM, 100nM and 200nM.
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Six strips were used, each deposited with 85ul of the target DNA solution at each of the five
aforementioned concentrations. A strip deposited with a solution containing 0nM target DNA
was considered as the control.
Next, the sample solution containing the target DNA was deposited onto the sample pad
of the LFA strip. Target DNA first hybridized with AuNP and detection probes (AuNP-DP) to
form AuNP-DP-target DNA complex at the conjugate pad. Then the solution containing AuNPDP-target DNA complex migrated by capillary action, passing the glass fiber part of the strip
into the test zone. At this point, a second hybridization took place between the AuNP-DP-target
DNA complex and the capture probes, producing a red signal at the test zone, observable by the
naked eyes (Figure 1.1). In the absence of target DNA in the sample solution, no colored signal
is observed at the test zone. The excess complex then reached the control zone where
hybridization with the control probe occurred, producing a second red signal observable at the
control zone. The red signal at the control zone indicates that the tool is working (Figure 1.2).
The tool was then placed in an incubator set at 69◦F (experiment 1) and 91◦F (experiment
2). These temperatures correspond to the average range of temperature variation reported in
regions of Sub-Saharan Africa and South Asia (National Centers for Environmental Information,
2016). The presence or absence of a colored signal at the test and control zones was observed
and noted at 5, 10, 15 and 30 minutes.
4.2.3 Image analysis
The LFA strips were imaged using an iPhone 6S Plus camera (Apple) on HDR (high
dynamic imaging) mode. To obtain the same lighting, the pictures were taken at the same time
and location on the laboratory bench. The strips were displayed on a blank sheet of white paper.
The images were processed without modification. Image analysis followed the steps described in
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Lathwal & Sikes (2008) supplemental publication. The color intensity of the signal at test and
control zones were analyzed in RGB (red, green, and blue) color space using ImageJ software
(National Institutes of Health). RGB is the most common color space used in image processing
devices and corresponds to the red, green, and blue elemental components defining a color
(Capitan-Vallvey et al., 2015). The darker an image is, the lower the color intensity; inversely,
the lighter the image, the higher the color intensity.
Each image was separated into a red, green, and blue channel. The minimum, maximum,
and average intensity of the signal at the control and test zones were measured on each channel
and the results were exported on MS Excel. Color intensity values of the signal was defined as
the mean intensity of all three channels at the test and control zones. Statistical analysis was
performed using Generalized Linear Model to evaluate the main effect of temperature, time and
target DNA concentration on the color intensity. Color intensity was expressed as the log10 of
the mean pixel value obtained from each channel.
4.3 Results
Colorimetric assessment of the signal was quantified as the mean color intensity of each
RGB channel at the test and control zones. Comparison of the colorimetric responses, under each
temperature, was done by tracking the changes in color intensity based on dilution series and
time interval (5 and 10 minutes). While the tool was observed for a total of 30 minutes, we are
only reporting on color change occurring within the first 10 minutes because no change was
noted after that time point.
4.3.1 Effect of time on color intensity
69oF processing environment. A red signal was progressively observed at the test zone (Figure
2). Color intensity values of the signal observed at the test and control zones were similar in each

65

RGB channels. So analysis of the colored intensity of the tool focused on the values obtained
from the Red channel. Change in color intensity of the signal occurred progressively over the
first 10 minutes, then remained constant. Except for the strip loaded with 1nM target DNA
solution, red signal at the test zone was observed on all strips at 5 minutes after application of the
sample solution. After 10 minutes, a light pink signal was also observable on the strip loaded
with 1nM target DNA solution. These findings are suggestive that the optimal maximal time for
colorimetric readout is 10 minutes when the tool is tested at 69◦F.
91oF processing environment. In a 91◦F environment, a light pink signal was observed after five
minutes at the test zone of the strips loaded with 10 and 25nM target DNA solution (Figure 1).
On the remaining strips (loaded with 1nM, 100nM and 200nM target DNA solutions), no colored
signal appeared at the test zone. At the control zone, reddish- pink signal was observable on each
strip. Lowest colored intensity, i.e., darkest colored signal, was obtained on the strip loaded with
10nM DNA concentration. After the first 10 minutes, a pink signal at the control zone of each
strip was observed. No colored signal was observed at the test zone expect for two strips (loaded
with 10 and 25nM target DNA solution).
Contrary to the results obtained under the 69◦F experiment, under 91◦F temperature, the
signal reduced, i.e., lighter colored signal is observable at the test zone. The findings suggest less
DNA hybridization at 91◦F. It seems that as temperature increases, the tool’s sensitivity
decreases.
4.3.2 Effect of concentration on color intensity
Concentration series of the target DNA was also used to assess the effectiveness of the
tool to detect the genetic material of targeted diarrheagenic pathogen in the two simulated
environments. Concentration gradient ranged from a minimum of 1nM to maximum of 200nM,
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and included dilution of the solution at 10nm, 25nm and 100nM. Observable red signal and their
change in color intensity were recorded at both 5 and 10 minutes. Color intensity of the test zone
decreased significantly by 3.8% in pixel value with every 1nM increase in target DNA
concentration (p = 0.035) (Figure 3). The findings indicate that target DNA concentration at 10
and 25nM concentration produced greatest color intensity; suggesting an increase hybridization
rate between the target DNA and capture probe at the test zone with these concentrations. In
addition, the results also suggest that the detection limit was achieved as low as 10nM and
optimum colorimetric response was obtained at 25nM target DNA concentration.
4.4 Discussion
The present study is a feasibility study testing the sensitivity of a diarrhea pathogen
identification tool to positively detect target sequence DNA of commercially available E. coli in
two different temperature environments. The tool is a LFA strip using gold nanoparticle as a
colorimetric probe to detect the presence of target DNA in the sample solution at different
concentrations. Red signal was observed at the test and control zones when target sequence DNA
solution is applied on the sample pad.
Previous studies have been done testing LFA strips using AuNP based on time,
temperature and target DNA concentration (Mao et al., 2009; Choi et al., 2016). In Mao and
colleagues’ study (2009), the authors tested the sensitivity of a low-cost nucleic acid biosensor to
detect commercial DNA based on time and target DNA oligos at various dilution series. Optimal
time for detection was reported to be 15 minutes. Their study’s findings suggest a linear
relationship between color intensity and concentration ranging from 1 to 100nM target DNA.
When looking at temperature variation and its impact of the LFA ability to detect target nucleic
acid, Choi et al. (2016) reported that optimal temperature for detection ranged between 131 and
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140oF.
In an environment of 69oF in our study, the tool showed the most visible signal at the
control and test zones. Increase in temperature from 69oF to 91oF seemed to be linked with a
decrease in color intensity of the red signal at the test zone. This may be due to various factors
including, AuNP precipitation, evaporation of the sample solution or melting point of the primers
or target DNA was reached or higher temperature might cause the double-stand DNA to
dissociate, hence reducing the hybridization with the capture probe (Choi et al., 2016).
We found the color intensity of the signal was negatively influenced by the target DNA
concentration gradient. In 69oF environment, the lowest color intensity values corresponding to
the darkest red signal was observed on the strips loaded with 10 and 25nM. The findings suggest
that 10 minutes is the optimal colorimetric readout time and the detection limit is achieved at
10nM while optimum red signal was achieved with 25nM target DNA concentration.
4.4.1 Limitations
This study assessed the tool sensitivity using only the target DNA of one bacterial species
at two different temperature conditions. The experiments were not repeated to assess replicability
and further validation of the tool. Additional optimization is needed at each step of development
of the LFA strips to address these limitations. Sensitivity and specificity of the tool will be tested
using various target DNA species at different concentration, as well as various concentration of
reagents, capture probes and SSC buffer which can promote DNA hybridization. Colorimetric
assessment will be further explored as method of analysis. Future optimization of the tool will
involve endogenous stool sample and testing the sensitivity at wider temperature variation and
under other environmental condition such as humidity and stool acidity.
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4.4.2 Implication for research and practice
Future research will involve reproducing the experiment at ambient conditions and
comparing it to various temperatures, target DNA concentrations and environmental conditions
such as relative humidity and stool acidity. In addition, tool sensitivity will be tested using other
commercial bacterial DNA and endogenous diarrhea and healthy stool.
Diagnostics for poverty-related conditions such as diarrheal diseases are limited because
they are mostly expansive and not adapted to the realities of many countries of the Developing
World. Currently, management of diarrheal diseases are symptom based. However, this approach
falls short to accurately identify the etiology and the severity of the disease as well as
distinguishing asymptomatic diseases. Developing low cost, precise and user-friendly POC
diagnostics is crucial in improving the management of diarrheal diseases at the bedside and the
community level. Development of such tool has the potential to continue reducing the impact of
diarrhea worldwide.
4.5 Conclusion
Diarrheal diseases remain the cause of millions of unnecessary deaths. Well-established
interventions have proven to significantly reduce the mortality rates, but their impact have been
limited in the last decade and even reversed in some areas. Identification of the etiologic agent
causing a diarrheal episode will result in reduction of diarrhea related morbidity and mortality
and prevent the unnecessary use of antibiotics. Existing standard diagnostics typically require
expensive material, sophisticated infrastructure, and highly trained personnel. POC testing has
been at the center of investigation to address global health issues such as diarrhea. The properties
of paper-based LFA offer the ability to develop low cost, rapid and accurate testing.
This study is significant because it evaluates the effectiveness of a diarrheal pathogen
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identification tool to positively detect the presence of pathogens causing diarrhea under
laboratory simulated climatic conditions. Testing the ability of the research tool under such
conditions, in a controlled laboratory environment, allows identification of the tool’s limitation
under high temperature. In addition, it also offers guidance for further optimization of the tool to
make it more sensitive and specific. The utilization of a simple, robust and accurate tool for the
identification of diarrheal pathogens is important in addressing the burden of diarrhea
worldwide.
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Figure 1. Schematic illustration of the pathogen identification tool
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2

Control zone

Test zone

1) A. Sample solution containing target DNA is applied on the sample pad. Hybridization of
target DNA with AuNP-DP to form AuNP-DP-target DNA complex. B. Migration of
AuNP-DN-target DNA complex through the nitrocellulose membrane. C. Hybridization
of AuNP-DP-target DNA with capture probe at the test zone. Hybridization of excess
AuNP-DP-target DNA complex with control probe at control zone. 2) Red signal
observable at the test and control zones.
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Figure 2. Effect of temperature, target DNA concentration and time on the pathogen
identification tool
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Figure 3. Main effect of Target DNA concentration on intensity of color signal
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CHAPTER FIVE
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5.1 Introduction
The ultimate goal of this dissertation was to contribute to our understanding of how the
management of childhood diarrhea has evolved over the last four decades, to identify the major
gaps in the current management and introduce a novel approach to address these gaps. The
research in Chapters 2 and 3 examined the limited use of ORT and breastfeeding, interventions
known to effectively prevent and treat diarrhea since the 1970’s. The study in Chapter 4 took a
closer look at the properties of a pathogen identification tool for diarrhea in two laboratory
simulated environments.
5.2 Major findings from Chapter 2
Observational studies reporting on physicians and pharmacists use of ORT in the
management of childhood diarrhea in South Asia were systematically reviewed. The main
objectives of the study was to assess what the literature reported on the use of ORT in treating
cases of childhood diarrhea and comparing the prescription behaviors before and after the
publication of the 2004 WHO guideline on the management of childhood diarrhea.
A systematic review of the available evidence suggested significant variability in
physicians and pharmacists reported ORT prescription rates in studies published before and after
the 2004 WHO guideline. Physicians appeared to prescribe more frequently ORT compared to
pharmacists. Reported knowledge and referencing of the WHO guideline for the management of
childhood diarrhea and its recommended ORT formulation were limited. These findings
reiterates the numerous reports on the limited use of ORT in the management of childhood
diarrhea.
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Most importantly, this study highlighted the methodological limitations of the published
research and their reports. Inconsistencies in the quality of the data collection and reporting calls
for the urgent need to develop standard methods to measure the outcomes, perform data
collection and report the results. Studies with stronger methodology would have the potential to
provide evidence that could identify the currents gaps and be the basis for the formulation of
more effective interventions addressing global health issues such as diarrhea.
5.3 Major findings from Chapter 3
A secondary data analysis of the IFPS2 survey on breastfeeding cessation during the first
6 months on the onset of diarrhea shows that: 1) breastfeeding for 6 months or more significantly
decreases the incidence of diarrhea before the first year of life; 2) infants who breastfed for less
than 3 months had the highest percentage of reported episodes of diarrhea at seven to 12 months;
3) increase in maternal age, higher income households and higher maternal education were
associated with a decrease in reported episodes of diarrhea episodes.
Since it is free, breastfeeding is considered the most cost-effective intervention to prevent
and treat diarrhea in infancy and early childhood. The results of the study reported in this chapter
provides evidence supporting the practice of exclusive breastfeeding for the first 6 months of
life. Infants who were breastfed for less than three months were the most affected by diarrhea
which might be associated with early introduction of food other than breastmilk. Most
importantly, the findings depicts the impact of social determinants such as education and
household income on early breastfeeding cessation and subsequent onset of diarrheal episodes.
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5.4 Major findings from Chapter 4
Findings from Chapter 4 present the properties of a diarrheagenic pathogen identification
tool to detect the presence of E coli at different dilution points. The tool was tested in laboratory
environments simulating temperatures characteristic of region of the world that are the most
affected by diarrhea. This feasibility study offers insight on the tool sensitivity based on
temperature, time and concentration variations, allowing further optimization.
The tool is a paper based lateral flow assay strip using gold nanoparticles as an indicator
of the presence of a target pathogen. Positive detection of E. coli was translated by the presence
of a hue of red colored signal at the test region on the strip. Ability to detect a pathogen was
assessed by the presence or absence of a colored signal at the test and control zones, the time
before observation of colored signal by the naked eyes and the color intensity of the signal.
At 69oF, 10 minutes after the sample solution was applied, the tool was able to detect the
presence of E. coli at a concentration varying from 1nM to 200nM. The colored signal were the
darkest on the strips containing 10 and 25nM solutions. In a 91oF environment, the strips were
only able to positively detect E. coli at 10 and 25nM after 5 minutes. Very light pink signal was
visible on the test and control zones at these concentrations. Generalized linear regressions
assessing the main effect of temperature, time and concentration on the color intensity suggested
that concentration gradient had a negative relation on the color intensity signal visible on the
strip.
These findings suggest that optimal detection of bacterial DNA occurs at concentration
between 10 and 25nM, 10 minutes after the initial application of the sample solution.
Temperature and increase in DNA concentration appear to limit the detection properties of the
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tool. The results will guide further optimization of the tool to ultimately become reliable and
relevant to resource-limited settings.
5.5 Limitations
The studies in this dissertation have several limitations. First the study in Chapter 2 is
based on the existing peer- reviewed literature limited to English language. Quality of the articles
included in the review was not assessed, which increase the risk of bias from inclusion of studies
with misrepresentative findings. Across studies, measurement of ORT prescriptions was
inconsistent. The studies differed greatly in their design and methodology, population and
settings. This variation limited the availability of quality data; hence unabling combination of the
studies’ findings into a meta-analysis and identification of defined ORT prescription patterns
across countries, settings and time periods.
Second, due to the nature of the data, i.e secondary data analysis, the study in Chapter 3
has some limitations. The major challenge was the fact that the study’s population was not
representative of the US population, so the findings could not be generalized at the national
level. In addition, the lack of data collected between the neonatal period and month 3 was a
missed opportunity to depict a clearer picture of early breastfeeding cessation and potential
influencing factors. Nationally representative studies with quality data collected monthly from
birth would produce stronger evidence on the preventive properties of breastfeeding on
childhood diarrhea.
The major limitation of the study in Chapter 4 is the sample size. Only one sample
solution was used to test the tools’ properties. Therefore, evaluation of the potential effect of
temperature, concentration and time on the color intensity is limited. Further test will be
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performed using commercial DNA of other bacteria such as Clostridium difficile and endogenous
stool sample under diverse environmental conditions such as wider temperature range, relative
humid and stool acidity.
5.6 Implication for policy and practice
The findings highlight the magnitude of inconsistencies in the current management of
childhood diarrhea and the need to develop alternative approach to contain the effect of the
health condition on the most vulnerable. The research furthers previous studies and international
institutions’ efforts to address the limited use of ORT and breastfeeding in the management of
diarrhea for the profit of unnecessary use of antibiotics and others therapies. These findings
support the on-going development of new technologies, economic and requiring minimal
instrumentation, to address global health issues.
In resource limited settings, where the medical system lacks modern laboratory
infrastructures and trained human resource, user-friendly technologies are urgently needed to
improve therapeutic management. The development of low cost lateral- flow immunoassays
used to identify etiologic agents causing diarrhea diseases, offers considerable potential to reduce
the burden of the disease and change the current practice guideline which is symptom based
(Yetisen, Akram, & Lowe, 2013). In addition, distinguishing bacterial from viral diarrheal
episodes would better inform healthcare providers to make the right prescriptions, hence
reducing the risk to unnecessarily prescribe antibiotics.
Regardless of the advances in health and technology, the porosity of geographical
boundaries and population migration due to globalization, foodborne illnesses, zoonotic and
waterborne diseases remain health issues that continue to fuel diarrheal diseases. This is mainly
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due to limited access to clean water and adequate sanitation, close human-animal contact and
ingestion of contaminated food. Programs testing the food and water supplies designated for
human consumption are limited in developing countries. Development of such tests has the
potential to play an essential role in medical diagnosis, food safety and control as well as
environmental monitoring for prevention and control of epidemics (Yetisen et al., 2013).
5.7 Implication for research
Given this dissertation’s findings, two areas for future research were mainly defined. First
and most importantly, there is an urgent need to design and perform observational studies with
strong methodology, data collection and reporting. Standard guideline for global health research
based on conceptual framework could be defined by international institution such as the WHO to
insure actions based on quality evidence and report of the findings. Research settings might
differ greatly based on the culture, language and demographics, but regardless of these
distinguishing features, common factors are associated with diarrhea. Therefore, overarching
guideline could be develop to collect and measure outcomes related to diarrheal diseases.
Multicountry surveys such as the Demographic Health Survey and Multiple Indicator
Cluster Survey (MICS) can also contribute to our understanding of global health issues as they
occur in the natural settings. Managed by the United States Agency for International
Development, DHS consists of numerous surveys lead to monitor and evaluate different
indicators of countries’ needs (Rutstein & Rojas, 2006). The analysis of such large dataset can be
another alternative to picture the prevalence of health behaviors such as diarrhea management.
Second area of research is the development of alternative platform technologies that
could address the identified gaps in the management of childhood diarrhea. The WHO has set
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seven criteria for the development of point of care diagnostic tests for resources-limited settings
(Kettler et al., 2004). These characteristics should guide research and prioritize the development
of low cost, rapid, sensitive and specific diagnostic assays. Besides the development of new
diagnostics, more scientific efforts should be invested in ensuring that these technologies are
adapted to the climate and environment specific to resource-limited settings.
5.8 Conclusion
A shift in priority away from diarrhea management has contributed to the slowing
progress in the full coverage of ORT and breastfeeding as preventive and treatment measures.
The development of point-of-care diagnostics at the service of global health issues is critical to
address the gap in using adequate management measures, hence improving child survival and
reducing morbidity and mortality rates caused by diarrheal diseases. Understanding the
fundamentals of capillary flow of the paper-based assays, detection of bacterial genetic material
and other characteristics of the technology will allow development of assays with better control
over the impact of temperature, moisture and other environmental factors.
The characteristics of paper and potential simplicity of the tool offer the potential for this
paper-based lateral flow assay to be utilized in settings with very limited resources while offering
accurate and highly sensitive information. However, having laboratory controlled data does not
always yield to accurate performance of the tool once deployed in the real world. Testing the
specificity and sensitivity of the tool in different clinical and community settings is required in
order to produce strong evidence to adopt the test within the standard management of diarrhea.
Such research will allow transformation of the tool from a prototype into a reproducible
diagnostic platform.
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